Field & Main Bank Boosts Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Field & Main Bank increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 0.7% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 3,396 shares of the medical equipment provider’s stock after buying an additional 24 shares during the period. Field & Main Bank’s holdings in Intuitive Surgical were worth $1,668,000 as of its most recent SEC filing.

Several other institutional investors also recently added to or reduced their stakes in ISRG. Creekmur Asset Management LLC increased its position in Intuitive Surgical by 200.0% during the 1st quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 42 shares during the period. Ridgewood Investments LLC bought a new stake in shares of Intuitive Surgical in the 2nd quarter valued at about $26,000. Delos Wealth Advisors LLC boosted its holdings in shares of Intuitive Surgical by 380.0% in the 1st quarter. Delos Wealth Advisors LLC now owns 72 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 57 shares in the last quarter. Godsey & Gibb Inc. boosted its holdings in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after buying an additional 35 shares in the last quarter. Finally, LRI Investments LLC bought a new stake in shares of Intuitive Surgical in the 1st quarter valued at about $30,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In related news, Director Amy L. Ladd sold 450 shares of the business’s stock in a transaction on Friday, September 13th. The shares were sold at an average price of $490.28, for a total value of $220,626.00. Following the completion of the sale, the director now owns 821 shares of the company’s stock, valued at approximately $402,519.88. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other Intuitive Surgical news, EVP Robert Desantis sold 240 shares of Intuitive Surgical stock in a transaction on Monday, August 12th. The shares were sold at an average price of $464.76, for a total transaction of $111,542.40. Following the sale, the executive vice president now owns 5,506 shares of the company’s stock, valued at $2,558,968.56. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Amy L. Ladd sold 450 shares of Intuitive Surgical stock in a transaction on Friday, September 13th. The stock was sold at an average price of $490.28, for a total transaction of $220,626.00. Following the sale, the director now directly owns 821 shares in the company, valued at approximately $402,519.88. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 68,246 shares of company stock valued at $33,839,308. 0.90% of the stock is owned by corporate insiders.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $536.45 on Friday. The firm has a market cap of $191.07 billion, a price-to-earnings ratio of 86.25, a price-to-earnings-growth ratio of 5.07 and a beta of 1.39. The company has a 50 day moving average price of $493.92 and a 200-day moving average price of $451.73. Intuitive Surgical, Inc. has a 1-year low of $269.49 and a 1-year high of $538.49.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping the consensus estimate of $1.24 by $0.32. The company had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. On average, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the stock. Barclays raised their price target on shares of Intuitive Surgical from $430.00 to $490.00 and gave the company an “overweight” rating in a report on Thursday, July 18th. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Stifel Nicolaus raised their price target on shares of Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a report on Friday, October 18th. The Goldman Sachs Group set a $604.00 price target on shares of Intuitive Surgical in a report on Friday, October 18th. Finally, Robert W. Baird lifted their target price on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research note on Thursday, October 17th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $513.74.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.